Cargando…
An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetically diverse HIV-1 clades have evolved, and a key question left unanswered is whether neutralizing antibodies can confer cross-clade protection in vivo. The novel human monoclonal antibody HGN194 was...
Autores principales: | Watkins, Jennifer D., Siddappa, Nagadenahalli B., Lakhashe, Samir K., Humbert, Michael, Sholukh, Anton, Hemashettar, Girish, Wong, Yin Ling, Yoon, John K., Wang, Wendy, Novembre, Francis J., Villinger, Francois, Ibegbu, Chris, Patel, Kalpana, Corti, Davide, Agatic, Gloria, Vanzetta, Fabrizia, Bianchi, Siro, Heeney, Jonathan L., Sallusto, Federica, Lanzavecchia, Antonio, Ruprecht, Ruth M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069056/ https://www.ncbi.nlm.nih.gov/pubmed/21483815 http://dx.doi.org/10.1371/journal.pone.0018207 |
Ejemplares similares
-
Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection
por: Lakhashe, Samir K., et al.
Publicado: (2011) -
Schistosoma mansoni Enhances Host Susceptibility to Mucosal but Not Intravenous Challenge by R5 Clade C SHIV
por: Siddappa, Nagadenahalli B., et al.
Publicado: (2011) -
R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models
por: Siddappa, Nagadenahalli B., et al.
Publicado: (2010) -
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
por: Sholukh, AM, et al.
Publicado: (2012) -
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys
por: Humbert, Michael, et al.
Publicado: (2008)